Early symptoms of dermatomyositis and antisynthetase syndrome;Frühsymptome der Dermatomyositis und des Antisynthetase-Syndroms

Zeitschrift fur Rheumatologie

Volumn 72, Issue 10, 2013, Pages 970-976

  Maurer, B ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Antisynthetase syndrome; Dermatomyositis; Morbidity; Mortality; Screening

Indexed keywords

ANTISYNTHETASE SYNDROME; ARTICLE; DERMATOMYOSITIS; EARLY DIAGNOSIS; HUMAN; PROGNOSIS; SCREENING; SYMPTOM;

DERMATOMYOSITIS; EARLY DIAGNOSIS; HUMANS; MASS SCREENING; MYOSITIS; PRIMARY PREVENTION; SECONDARY PREVENTION;

EID: 84891601228     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-013-1196-8     Document Type: Article

References (34)

1. Bodolay E, Csiki Z, Szekanecz Z et al (2003) Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 21(3):313-320
2. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344-347
3. Griggs RC, Askanas V, DiMauro S et al (1995) Inclusion body myositis and myopathies. Ann Neurol 38(5):705-713
4. Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14(3):275-285
5. Katzap E, Barilla-LaBarca ML, Marder G (2011) Antisynthetase syndrome. Curr Rheumatol Rep 13(3):175-181
6. Oh TH, Brumfield KA, Hoskin TL et al (2007) Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc 82(4):441-447
7. Fathi M, Dastmalchi M, Rasmussen E et al (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 63(3):297-301
8. Gupta R, Wayangankar SA, Targoff IN, Hennebry TA (2011) Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 148(3):261-270
9. Kalluri M, Oddis CV (2010) Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 31(3):501-512
10. Yoshifuji H, Fujii T, Kobayashi S et al (2006) Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 39(3):233-241
11. Sato S, Kuwana M (2010) Clinically amyopathic dermatomyositis. Curr Opin Rheumatol 22(6):639-643
12. Rockerbie NR, Woo TY, Callen JP, Giustina T (1989) Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol 20(4):629-632
13. Dugan EM, Huber AM, Miller FW, Rider LG (2009) Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies. Dermatol Online J 15(2):1
14. Dugan EM, Huber AM, Miller FW, Rider LG (2009) Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies. Dermatol Online J 15(2):2
15. Rider LG, Werth VP, Huber AM et al (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 63(Suppl 11):S118-S157
16. Rider LG, Koziol D, Giannini EH et al (2010) Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 62(4):465-472
17. Alexanderson H, Broman L, Tollback A et al (2006) Functional index-2: validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum 55(1):114-122
18. Agarwal S, Kiely PD (2006) Two simple, reliable and valid tests of proximal muscle function, and their application to the management of idiopathic inflammatory myositis. Rheumatology (Oxford) 45(7):874-879
19. Ghirardello A, Bassi N, Palma L et al (2013) Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep 15(6):335
20. Shen H, Xia L, Lu J, Xiao W (2011) Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis. Scand J Rheumatol 40(3):217-220
21. Mercer LK, Moore TL, Chinoy H et al (2010) Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) 49(9):1699-1705
22. Degardin A, Morillon D, Lacour A et al (2010) Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skeletal Radiol 39(12):1219-1227
23. Blijham PJ, Hengstman GJ, Ter Laak HJ et al (2004) Muscle-fiber conduction velocity and electromyography as diagnostic tools in patients with suspected inflammatory myopathy: a prospective study. Muscle Nerve 29(1):46-50
24. Fredericks EJ (1994) Electromyography in polymyositis and dermatomyositis. Muscle Nerve 17(10):1235-1236
25. Paganoni S, Amato A (2013) Electrodiagnostic evaluation of myopathies. Phys Med Rehabil Clin N Am 24(1):193-207
26. Dalakas MC (2012) Pathogenesis and therapies of immune-mediated myopathies. Autoimmun Rev 11(3):203-206
27. Mozaffar T, Pestronk A (2000) Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry 68(4):472-478
28. Grundtman C, Bruton J, Yamada T et al (2010) Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J 24(2):570-578
29. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138(6):1464-1474
30. Suliman YA HD, Nguyen-Kim TDL, Maurer B et al (2013) High rate of false negatives in the early detection of interstitial lung disease associated with systemic sclerosis by pulmonary function tests. Ann Rheum Dis 72:S3,500-501 2013
31. Lynch DA, Travis WD, Muller NL et al (2005) Idiopathic interstitial pneumonias: CT features. Radiology 236(1):10-21
32. Winklehner A, Berger N, Maurer B et al (2012) Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices. Ann Rheum Dis 71(4):549-552
33. Fathi M, Barbasso Helmers S, Lundberg IE (2012) KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. J Intern Med 271(6):589-597
34. Buchbinder R, Forbes A, Hall S et al (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134(12):1087-1095